老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

众巢医学

0.1990
+0.01125.96%
成交量：12.82万
成交额：2.50万
市值：612.00万
市盈率：-1.05
高：0.2044
开：0.1937
低：0.1900
收：0.1878
52周最高：1.59
52周最低：0.1858
股本：3,075.39万
流通股本：1,865.60万
量比：0.25
换手率：0.69%
股息：- -
股息率：- -
每股收益(TTM):-0.1900
每股收益(LYR):-0.1236
净资产收益率：-5.93%
总资产收益率：-2.90%
市净率：0.30
市盈率(LYR):-1.61

数据加载中...

总览公司新闻资讯公告
2026/01/15

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC问询函

Form CORRESP - Correspondence
2025/06/07

SEC问询函

Form CORRESP - Correspondence
2025/05/20

SEC问询函

Form CORRESP - Correspondence
2025/05/07

SEC问询函

Form CORRESP - Correspondence
2025/04/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC问询函

Form CORRESP - Correspondence
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

超过5%披露

General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多